Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SET, ORAL ADMINISTRATION

K-Number: K760251 · 1976-09-15

ApplicantCis Radiopharmaceuticals, Inc.
Decision Date1976-09-15
Product CodeLEY
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

SET, ORAL ADMINISTRATION is the device name listed in this FDA 510(k) record. The listed applicant is Cis Radiopharmaceuticals, Inc.. It received FDA 510(k) clearance on 1976-09-15 under 510(k) number K760251. The device is classified under product code LEY. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SET, ORAL ADMINISTRATION?

SET, ORAL ADMINISTRATION is a medical device that received FDA 510(k) clearance on 1976-09-15. The listed applicant is Cis Radiopharmaceuticals, Inc.. The 510(k) number is K760251.

When did SET, ORAL ADMINISTRATION receive FDA 510(k) clearance?

SET, ORAL ADMINISTRATION received FDA 510(k) clearance on 1976-09-15, under 510(k) number K760251.

Who is the listed applicant for SET, ORAL ADMINISTRATION?

The FDA 510(k) record lists Cis Radiopharmaceuticals, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SET, ORAL ADMINISTRATION?

The FDA product code for SET, ORAL ADMINISTRATION is LEY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Cis Radiopharmaceuticals, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K791860FERRITIN RIA KITK792063FOLLICLE STIMULATING HORMONE (FSH) KITK791202RIA KIT FOR TRYPSINK792000LUTEINIZING HORMONE (LH) RIAK791051PROGESTERONE RADIOIMMUNOASSAY KITK790003RIA KIT, PROLACTIN

View all 9 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑